secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pacira BioSciences, Inc. (PCRX)
CIK:        0001396814
Form:       8-K
Filed at:   2025-06-13T23:59:59+00:00
Accession:  0001396814-25-000089
Event type: other_material
Sentiment:  negative
Materiality: 0.65
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Pacira shareholders approve 2.5M share increase to equity plan; say-on-pay fails
--------------------------------------------------------------------------------

- Stockholders approved Amended 2011 Plan adding 2,500,000 new shares for future grants.
- Advisory say-on-pay resolution failed: 14,752,829 for, 22,595,202 against, 33,777 abstain.
- Board will hold annual say-on-pay votes based on frequency vote (1 year: 35,312,982 votes).
- Three Class II directors elected: Bigal, Lee, Young; no other director changes.
- KPMG ratified as auditor for FY 2025 with 40,022,569 for, 352,947 against.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1396814/000139681425000089/0001396814-25-000089-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1396814/000139681425000089/pcrx-20250610.htm
  HTML page:      https://secwatch.observer/filing/0001396814-25-000089

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer